跳至主要内容
临床试验/JPRN-UMIN000001872
JPRN-UMIN000001872已完成3 期

Effect of Landiolol as an adjunct to Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction - Ibaraki Landiolol for AMI study (i-LAND study)

Cardiovascular Division, University of Tsukuba, Graduate School of Comprehensive Human Sciences0 个研究点目标入组 88 人开始时间: 2009年4月11日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) history of OMI or CABG 2) LMT 3) suspected aortic dissection 4) systolic blood pressure of less than 90 mmHg or bradycardia of less than 60 beats/min 5) more than II-AV block or 2 bundle block 6) severe liver and/or kidney dysfunction 7) bronchial athma 8) history of beta-blocker or amiodarone 9) history of side effects or contraindication of beta-blocker

研究者

发起方
Cardiovascular Division, University of Tsukuba, Graduate School of Comprehensive Human Sciences

相似试验